Dextrose Monohydrate 5% Injection shortage
Dextrose Monohydrate 5% Injection is currently listed in shortage by the FDA. The FDA lists 36 affected products. The reported reason: Demand increase for the drug. This page was last refreshed from FDA data on Oct 2, 2026.
Dextrose 5% injection (D5W) has been on the FDA shortage list for over a year due to high demand. All strengths still have available supply, and makers including Baxter, B. Braun, and Hospira have not reported a shortage.
Don’t stop or change your therapy on your own — ask your pharmacist about other manufacturers (see options) and your prescriber about a long-term plan.
Do you take this drug? See the ‘What to do’ recommendation from Dr. Brian Staiger, PharmD →What’s in shortage — at a glance
These figures count only the manufacturers that reported this shortage to the FDA — not every company that makes Dextrose Monohydrate 5% Injection. Other makers that haven’t reported a problem are shown in the green card below.
Shortage timeline
-
Sep 22, 2026Currently in shortage36 of 36 products affected.
-
Sep 17, 2026FDA refreshed this shortage record16 products updated.
-
Sep 16, 2026FDA refreshed this shortage record10 products updated.
-
Sep 15, 2026FDA refreshed this shortage record5 products updated.
-
Jul 20, 2026More presentations reported1 more product added to the shortage.
-
Feb 14, 2022First reported to the FDA35 products first listed.
Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.
What exactly is on backorder — by manufacturer
Manufacturer: B. Braun Medical Inc. 📞 800-227-2862 5 NDCS click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 0264-1510-32) | — | Available | — | — |
| Current | Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 0264-1510-31) | — | Available | — | — |
| Current | Dextrose Monohydrate 5%, Injection, 5 g/100 mL (NDC 0264-7510-20) | — | Available | — | — |
| Current | Dextrose Monohydrate 5%, Injection, 5 g/100 mL (NDC 0264-7510-10) | — | Available | — | — |
| Current | Dextrose Monohydrate 5%, Injection, 5 g/100 mL (NDC 0264-7510-00) | — | Available | — | — |
Manufacturer: Baxter Healthcare 📞 888-229-0001 16 NDCS click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-38) | — | Available | — | — |
| Current | Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0338-0551-18) | — | Available | — | — |
| Current | Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-03) | — | Available | — | — |
| Current | Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-02) | — | Available | — | — |
| Current | Dextrose 5% In Plastic Container, Injection, 2.5 g/50 mL (NDC 0338-9664-40) | — | Available | — | — |
| Current | Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-48) | — | Available | — | — |
| Current | Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0338-9666-35) | — | Available | — | — |
| Current | Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-31) | — | Available | — | — |
| Current | Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0338-0070-10) | — | Available | — | Demand increase for the drug |
| Current | Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-10) | — | Available | — | — |
| Current | Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0338-0551-11) | — | Available | — | — |
| Current | Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-18) | — | Available | — | — |
| Current | Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-41) | — | Available | — | — |
| Current | Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-11) | — | Available | — | — |
| Current | Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0338-0074-30) | — | Available | — | — |
| Current | Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0338-0078-20) | — | Available | — | — |
Manufacturer: Fresenius Kabi USA, LLC 📞 888-386-1300 5 NDCS click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 65219-456-60) | — | Available | Check wholealers for inventory | — |
| Current | Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 65219-464-50) | — | Available | Check wholesalers for inventory | — |
| Current | Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 65219-460-20) | — | Available | Check wholesalers for inventory | — |
| Current | Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 65219-462-10) | — | Available | Check wholesalers for inventory | Demand increase for the drug |
| Current | Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 65219-458-30) | — | Available | Check wholesalers for inventory | — |
Manufacturer: Otsuka ICU Medical LLC 📞 1-866-829-9025 or [email protected] 10 NDCS click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7922-55) | — | Available | This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical. | — |
| Current | Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7923-20) | — | Available | This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical. | — |
| Current | Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7922-61) | — | Available | This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical. | — |
| Current | Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7923-13) | — | Available | This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical. | — |
| Current | Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7923-36) | — | Available | This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical. | — |
| Current | Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7923-23) | — | Available | This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical. | — |
| Current | Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7922-02) | — | Available | This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical. | — |
| Current | Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7922-09) | — | Available | This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical. | — |
| Current | Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7923-37) | — | Available | This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical. | — |
| Current | Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7922-03) | — | Available | This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical. | — |
These rows are manufacturer reports to the FDA for Dextrose Monohydrate 5% Injection — they do not necessarily cover every manufacturer that makes this drug. A company appears here only if it told the FDA it has a supply problem, so other makers may still have stock. That’s the basis for the Where else can I get Dextrose Monohydrate 5% Injection? options further down this page.
Why is Dextrose Monohydrate 5% Injection in shortage?
Dextrose 5% injection (also called "D5W") is on the FDA shortage list mainly because more people need it than usual — demand has gone up beyond what suppliers can easily keep up with. The specific reason reported to the FDA is a demand increase. Fresenius Kabi, Baxter Healthcare, B. Braun Medical, and Otsuka/ICU Medical have all reported their products to the FDA, and at this time all listed package sizes — including 100 mL and 1,000 mL bags — are marked as available from these manufacturers.
Even though the products are listed as currently available, Fresenius Kabi noted that inventory can vary, so stock levels may not be consistent everywhere. The shortage listing is essentially a heads-up that demand has been outpacing the usual supply, which can cause spotty availability at certain locations even when the product technically exists in the system.
Based on the manufacturer-reported reason(s) and notes on file with the FDA for Dextrose Monohydrate 5% Injection, summarized in plain English by HelloPharmacist. A drug can be short for more than one reason, and the FDA updates these as manufacturers report changes.
What should I do if I take Dextrose Monohydrate 5% Injection?
Dextrose Monohydrate 5% Injection is currently on the FDA shortage list, but the supply picture here is reassuring. All four strengths on this record still have an available source, and every one of the four manufacturers listed is reporting supply.
To be specific, each strength — 50 mg/1 mL, 5 g/100 mL, 50 g/1000 mL, and 2.5 g/50 mL — currently has an available source. None of these strengths is listed as having no source right now. The reason the FDA gives is simply an increase in demand for this product, not a manufacturing failure. Because this is a widely used injectable solution, it was placed on the list even though supply is still flowing, which is why the overall risk is rated low.
Here is what I suggest:
- Do not stop, skip, or change how you use this medicine on your own.
- Ask your pharmacy or facility to order your strength; they can check wholesalers and multiple manufacturers, several of whom report stock.
- The same medicine is available from other makers (such as Baxter, B. Braun, Fresenius Kabi, and ICU Medical) — your pharmacy may be able to source one of these, though it may not be in local stock.
- If your exact product cannot be found, ask your prescriber or pharmacist about suitable options.
Manufacturer contact numbers are listed on this page for reference; pharmacies usually make these calls. This information comes from national, manufacturer-reported FDA data and may not match your local pharmacy's actual stock.
- Don’t stop or change the medication on your own — talk to your prescriber first.
- If this is part of an ongoing or essential regimen (for example HIV treatment or prevention, seizure, heart, transplant, diabetes or mental-health medicines), do not skip or ration doses — contact your pharmacist or prescriber right away to arrange continued supply before you run out.
- Ask your pharmacy to check other manufacturers, strengths, package sizes, and nearby stores.
- Ask your prescriber whether a different strength, formulation, or the brand/generic version is appropriate.
Uses, dosing, side effects, prices, and the complete FDA label — written in plain English and pharmacist-reviewed.
Where else can I get Dextrose Monohydrate 5% Injection?
FDA shortages are manufacturer-reported — a company only shows up on the shortage list if it told the FDA it has a supply problem, so not every maker of Dextrose Monohydrate 5% Injection is necessarily short. Below we pull together the other still-marketed options that are not reported in shortage: the same medicine from manufacturers that haven’t reported a problem, and alternative dosage forms. These may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.
Same medicine, other manufacturers (not reported short)
Same active ingredient, dosage form & route as the shortage (matched on the FDB HICL ingredient code), from makers that have not filed a shortage with the FDA:
| Product | Strength | Form / route | Manufacturer | NDC |
|---|---|---|---|---|
| Dextrose | DEXTROSE MONOHYDRATE 50 mg/mL | Injection, Solution · Intravenous | B. Braun Medical Inc. | 00264-1510-36 |
| Dextrose | DEXTROSE MONOHYDRATE 50 g/1000mL | Injection, Solution · Intravenous | Baxter Healthcare Corporation | 00338-0017-01 |
| Dextrose | DEXTROSE MONOHYDRATE 5 g/100mL | Injection, Solution · Intravenous | Baxter Healthcare Corporation | 00338-0062-30 |
| Dextrose | DEXTROSE MONOHYDRATE 2.5 g/50mL | Injection · Intravenous | Baxter Healthcare Company | 00338-9143-30 |
| Dextrose | DEXTROSE MONOHYDRATE 5 g/100mL | Injection · Intravenous | Baxter Healthcare Company | 00338-9147-30 |
| Dextrose | DEXTROSE MONOHYDRATE 2.5 g/50mL | Injection, Solution · Intravenous | Baxter Healthcare Corporation | 00338-9649-75 |
| Dextrose | DEXTROSE MONOHYDRATE 50 mg/mL | Injection, Solution · Intravenous | Hospira, Inc. | 00409-7100-02 |
| Dextrose | DEXTROSE MONOHYDRATE 5 g/100mL | Injection, Solution · Intravenous | ICU Medical, Inc. | 00990-7922-53 |
| Dextrose | DEXTROSE MONOHYDRATE 50 mg/mL | Injection, Solution · Intravenous | Becton Dickinson and Company | 17271-0720-02 |
| Dextrose | DEXTROSE MONOHYDRATE 50 mg/mL | Injection, Solution · Intravenous | Fresenius Kabi USA, LLC | 63323-0624-10 |
| Dextrose | DEXTROSE MONOHYDRATE 2500 mg/50mL | Injection, Solution · Intravenous | Fresenius Kabi USA, LLC | 65219-0234-10 |
| Dextrose | DEXTROSE MONOHYDRATE 5000 mg/100mL | Injection, Solution · Intravenous | Fresenius Kabi USA, LLC | 65219-0236-10 |
Therapeutic equivalents & pricing 3 productsclick to expand
Orange Book–rated equivalents of the affected strengths, with the latest NADAC price (a federal retail-acquisition benchmark, not your copay) and an evidence-based availability label. Cheapest first.
| Product | Manufacturer | Package | NADAC $/unit | AB rating | Availability |
|---|---|---|---|---|---|
| Dextrose 50 mg/mL | B. | 100 ml | — | AP | FDA listed |
| Dextrose 50 mg/mL | B. | 50 ml | — | AP | FDA listed |
| Dextrose 5 g/100mL | B. | 250 ml | — | AP | FDA listed |
Equivalents share the same ingredient, strength, dosage form and route; an AB rating means the FDA considers them substitutable. NADAC is a national retail-pharmacy acquisition benchmark from CMS — not what you pay. Availability is inferred from recent pricing, not a stock check.
Other drugs in the same treatment class
These are different medicines — not other versions of Dextrose Monohydrate 5% Injection — that fall in the same broad treatment class (iv solutions: dextrose-water) . They are not automatic substitutes: they can differ in how they work, dosing, effectiveness, side effects and what they’re approved to treat. Do not switch on your own. This list is for information only — ask your prescriber or pharmacist whether any of them is appropriate for you.
Identity & classification
Where does this data come from?
Other endocrinology/metabolism, gastroenterology, other, pediatric shortages
Dextrose Monohydrate 5% Injection shortage FAQs
Is Dextrose Monohydrate 5% Injection in shortage?
Why is Dextrose Monohydrate 5% Injection in shortage?
Which products are affected?
When will Dextrose Monohydrate 5% Injection be available again?
Can I still get Dextrose Monohydrate 5% somewhere?
What should I do if I take Dextrose Monohydrate 5% Injection?
Still have a question about the Dextrose Monohydrate 5% Injection shortage?
Ask a pharmacist about this shortage →View Dextrose Monohydrate 5% Injection on the FDA drug-shortage database →
Where does this data come from?
/drug/shortages) — drug, manufacturer & contact, NDC/product, status, availability, reason, therapeutic category and posting/update dates. Current / To Be Discontinued = active; Resolved is kept for history. The Supply-Risk rating is assessed per active ingredient and adds the FDA NDC Directory (still-marketed manufacturers by ingredient & form); same-medicine and equivalent products use First Databank classification + CMS NADAC pricing; Medicaid use + most-affected states come from CMS Medicaid State Drug Utilization Data. Reference only — confirm current status with the manufacturer or FDA before acting on it.